Walk into a Whole Foods in California and you'll find ashwagandha and turmeric supplements in multiple forms—powders, capsules, tinctures—displayed alongside ginseng and echinacea. Five years ago, this didn't exist. Today, Ayurveda is a $10 billion global market, and growing faster than conventional pharmaceuticals. India's 5,000-year-old medical system, once dismissed as superstition by colonial administrators and postcolonial modernizers alike, is suddenly fashionable. The irony is sharp: the West is validating what India abandoned.

The appeal is straightforward. Ayurveda offers something modern medicine increasingly admits to lacking: a systematic approach to prevention rather than mere disease management. It treats the person, not the symptom. It respects individual variation through the Prakriti framework—the idea that physiology varies by constitution. This resonates deeply with wellness-conscious consumers tired of one-size-fits-all treatment.

But global expansion creates problems. Some are commercial: wellness companies cherry-pick Ayurvedic concepts, strip away their coherence, and market them as exotic alternatives to real medicine. Curcumin is real; the claim that turmeric cures cancer is not. Ashwagandha genuinely helps with stress; calling it "nature's medicine" without mentioning dosage or contraindications is marketing, not medicine. The line between education and exploitation is razor-thin and frequently crossed.

A deeper tension exists between Ayurveda's paradigm and science's. Ayurveda developed through millennia of observation and experiential knowledge. Modern medicine requires randomized controlled trials, plausible mechanisms, and reproducibility. Some Ayurvedic interventions pass scientific scrutiny: yoga genuinely improves flexibility and reduces anxiety. Meditation demonstrably affects brain structure. Turmeric's curcumin has anti-inflammatory properties. But many traditional claims—that the body's doshas balance with planetary alignment, that certain health conditions reflect character flaws—don't fit modern physiology.

The uncomfortable question is whether this matters. If Ayurvedic treatment works through placebo effects combined with wise lifestyle advice, is that less valuable than pharmaceutical intervention? An Ayurvedic practitioner telling a patient to sleep more, eat better, reduce stress, and exercise might achieve results not through ancient wisdom but through simple human truths that medicine often forgets. Yet without scientific validation, practitioners can't distinguish actual effects from placebo, safe interventions from harmful ones.

This becomes dangerous at scale. A practitioner trained in classical Ayurveda but unfamiliar with modern pathophysiology might miss a thyroid condition, a tumorbrain, a kidney disease—conditions requiring urgent intervention. Integrating Ayurveda into healthcare systems requires establishing training standards, credential recognition, and integration with medical oversight. That infrastructure barely exists globally, much less systematically.

There's also the question of supply and ethics. Global demand for ashwagandha has created harvesting pressures in India that are now unsustainable. The same is true for turmeric in Kerala, Himalayan medicinal plants, and traditional sandalwood. Scaling Ayurveda means scaling environmental damage unless India develops sustainable cultivation at global volumes. Additionally, much of Ayurveda is unpatented traditional knowledge. As companies profit from Ayurvedic plants and formulations, India receives minimal benefit and no credit—textbook biopiracy.

The most realistic path forward isn't Ayurveda replacing modern medicine but integration. Yoga and meditation have achieved this successfully—they're now part of standard mental health treatment in many Western clinics. Specific Ayurvedic herbs with demonstrated benefits could follow the same trajectory: identified, studied, validated, then incorporated into evidence-based practice. Lifestyle principles from Dinacharya (daily routine) could inform preventive medicine. The Prakriti concept could inform personalized medicine.

But this requires humility on both sides. Ayurveda must abandon magical thinking and embrace scientific methodology. Modern medicine must acknowledge that its disease-focused, reductionist model leaves gaps that holistic approaches can fill. Neither tradition has monopoly on truth.

The real test of Ayurveda's global future isn't whether wellness retreats fill up or whether turmeric supplements sell out. It's whether India can steward authentic transmission while opening the system to rigorous study. Can Ayurveda remain itself while becoming scientific? That's a harder question than scaling to the global market—and the answer will determine whether this is a genuine renaissance or a commercial trend that collapses when novelty wears off.